MedPath

Effects of combination treatment with Tizanidine and long-acting Stimulants in ADHD

Phase 3
Recruiting
Conditions
Attention-deficit hyperactivity disorders.
Attention-deficit hyperactivity disorders
Registration Number
IRCT20230619058530N2
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Clinical diagnosis of Attention Deficit Hyperactivity Disorder according to DSM-5 criteria
completing the informed consent form by parent and patient
negative history for any chronic medical diseases
negative history for drug induced allergy
negative history of receiving any Anti hypertensive, Alpha blockers or Beta blockers during recent three months before study
Lack of history of any comorbid psychiatric disorder

Exclusion Criteria

Any unexpected physical or mental condition that effects on treatment regimen
unwillingness of patients or parents to continue study procedure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ADHD severity. Timepoint: Before intervention and 1,2 months after intervention. Method of measurement: conners questioner.
Secondary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: Before intervention and 1,2 months after intervention. Method of measurement: Standard mercury sphygmomanometer.
© Copyright 2025. All Rights Reserved by MedPath